Deep Cerebellar Nuclear Neurons

Deep Cerebellar Nuclear Neurons

Overview

<table class="infobox infobox-cell">
<tr>
<th class="infobox-header" colspan="2">Deep Cerebellar Nuclear Neurons</th>
</tr>
<tr>
<td class="label">Name</td>
<td><strong>Deep Cerebellar Nuclear Neurons</strong></td>
</tr>
<tr>
<td class="label">Type</td>
<td>Cell Type</td>
</tr>
</table>

Deep Cerebellar Nuclear Neurons

Overview

<table class="infobox infobox-cell">
<tr>
<th class="infobox-header" colspan="2">Deep Cerebellar Nuclear Neurons</th>
</tr>
<tr>
<td class="label">Name</td>
<td><strong>Deep Cerebellar Nuclear Neurons</strong></td>
</tr>
<tr>
<td class="label">Type</td>
<td>Cell Type</td>
</tr>
</table>

Deep Cerebellar Nuclear Neurons plays an important role in the study of neurodegenerative diseases.[@Stoodley2012] This page provides comprehensive information about this topic, including its mechanisms, significance in disease processes, and therapeutic implications.

Introduction

Deep cerebellar nuclear (DCN) neurons constitute the sole output structure of the cerebellar cortex, serving as the critical relay station that transmits processed cerebellar information to extracerebellar targets including the thalamus, red nucleus, brainstem, and spinal cord.[@ruigrok2011] These neurons receive convergent input from Purkinje cell axons (the[@Hull2020] sole output of the cerebellar cortex), mossy fiber collaterals, climbing fiber collaterals, and various neuromodulatory systems, integrating this information to generate coordinated motor commands and participate in cognitive functions [1][2]. DCN dysfunction contributes to the pathogenesis of numerous neurodegenerative diseases including Alzheimer's disease (AD), Parkinson's disease (PD), spinocerebellar ataxias (SCAs), and multiple system atrophy (MSA), making them crucial therapeutic targets [3][4].

The deep cerebellar nuclei consist of four paired nuclei: the fastigial nucleus (medial), globose nucleus (anterior interposed), emboliform nucleus (posterior interposed), and dentate nucleus (lateral). Each nucleus has distinct connectivity patterns and functional roles in motor coordination, balance, eye movements, and increasingly recognized cognitive functions [5][6].

Anatomy and Morphology

Nuclear Organization

The deep cerebellar nuclei are located in the cerebellar white matter core, dorsal to the fourth ventricle:

Fastigial Nucleus (FN):

• Location: Medial cerebellar nucleus, closest to the vermis [7]
• Function: Controls axial and proximal limb musculature [8]
• Target structures: Vestibular nuclei, reticular formation, thalamus [9]

• Globose nucleus (GN): Anterior interposed nucleus [10]
• Emboliform nucleus (EN): Posterior interposed nucleus [11]
• Function: Controls distal limb musculature [12]
• Target structures: Red nucleus, thalamus, brainstem [13]

• Location: Lateral cerebellar nucleus, largest of DCN [14]
• Function: Controls voluntary movements, cognitive processing [15]
• Target structures: Thalamus (ventrolateral nucleus), red nucleus [16]

Neuronal Types

DCN contain multiple neuronal populations with distinct morphologies and functions:

Projection Neurons (70-80% of DCN neurons):

• Large neurons: 15-30 μm soma diameter [17]
• Dendritic trees: Extensive, aspiny dendrites receiving Purkinje cell input [18]
• Axonal projections: Long axons to thalamus, red nucleus, brainstem [19]

• Small neurons: 8-15 μm soma diameter [20]
• Inhibitory: GABAergic neurons modulating DCN output [21]
• Collateral systems: Axon collaterals modulating nearby projection neurons [22]

Synaptic Inputs

DCN neurons receive diverse synaptic inputs:

Purkinje Cell Input:

• Inhibitory GABAergic projections from Purkinje cells [23]
• Topographically organized: vermal Purkinje cells project to FN, hemispherical to DN [24]
• High-frequency synaptic input modulates DCN firing [25]

• Excitatory glutamatergic input from mossy fiber rosettes [26]
• Provide direct excitation supplementing Purkinje cell input [27]
• Originates from cerebellar granule cells via parallel fiber collaterals [28]

• Excitatory input from climbing fiber branches [29]
• Modulate DCN activity during motor learning [30]
• Originates from inferior olive climbing fiber branches [31]

• Noradrenergic input from locus coeruleus [32]
• Serotonergic input from raphe nuclei [33]
• Cholinergic input from brainstem nuclei [34]

Molecular Composition

Neurotransmitter Systems

DCN neurons utilize both excitatory and inhibitory neurotransmission:

GABA (Inhibitory):

• Primary neurotransmitter of Purkinje cell terminals [35]
• GABA_A and GABA_B receptor-mediated inhibition [36]
• Critical for shaping DCN output patterns [37]

• Released from mossy fiber and climbing fiber collaterals [38]
• AMPA, NMDA, and kainate receptor-mediated excitation [39]
• Essential for maintaining DCN firing [40]

Receptor Expression

GABA Receptors:

• GABA_A receptors: Ionotropic, fast synaptic inhibition [41]
• GABA_B receptors: Metabotropic, slower inhibition [42]
• Benzodiazepine binding sites: Modulate GABA_A function [43]

• AMPA receptors: Fast excitatory transmission [44]
• NMDA receptors: Synaptic plasticity, voltage-dependent magnesium block [45]
• mGluR1/5: Modulatory role in DCN function [46]

• HCN channels: Hyperpolarization-activated cyclic nucleotide-gated channels [47]
• KV3 channels: Fast-spiking properties [48]
• T-type calcium channels: Low-threshold calcium spikes [49]

Calcium-Binding Proteins

DCN neurons express calcium-binding proteins determining firing properties:

• Parvalbumin: Fast-spiking phenotype [50]
• Calbindin: Calcium buffering [51]
• Calretinin: Subtype-specific expression [52]

Electrophysiology

Firing Properties

DCN neurons exhibit distinctive firing patterns:

Regular Firing:

• Spontaneous firing rates: 10-50 Hz in vivo [53]
• Highly regular pacemaking in vitro [54]
• KV3 channel-dependent fast-spiking [55]

• Triggered by excitatory input [56]
• T-type calcium channel-dependent [57]
• Functional significance in motor learning [58]

• Post-inhibitory rebound bursting [59]
• Following Purkinje cell pauses [60]
• Encodes error signals [61]

Membrane Properties

Resting Membrane Potential:

• Resting potential: -55 to -65 mV [62]
• Leak conductances maintain steady state [63]

• Moderate input resistance: 50-200 MΩ [64]
• Determines synaptic integration [65]

• Fast membrane time constants: 2-10 ms [66]
• Enable precise temporal coding [67]

Functions in Normal Physiology

Motor Control

DCN neurons play essential roles in motor coordination:

Movement Timing:

• Generate precise temporal patterns [68]
• Coordinate muscle activation sequences [69]
• Essential for skilled movements [70]

• Store learned motor patterns [71]
• Receive error signals from climbing fibers [72]
• Modulate Purkinje cell output [73]

• Fastigial nucleus controls postural adjustments [74]
• Coordinate proximal and axial muscles [75]
• Integrate vestibular information [76]

Cognitive Functions

Emerging evidence implicates DCN in cognitive processing:

Executive Function:

• Dentate nucleus contributes to cognitive flexibility [77]
• Prefrontal cortex interactions [78]
• Working memory operations [79]

• Cerebellar-thalamic-cortical loops for language [80]
• Syntax processing [81]
• Verbal fluency [82]

• Cerebello-limbic pathways [83]
• Emotional motor expressions [84]
• Mood modulation [85]

Sensorimotor Integration

DCN integrate multiple sensory modalities:

Proprioceptive Input:

• Muscle spindle information [86]
• Joint position sense [87]
• Movement feedback [88]

• Balance and spatial orientation [89]
• Eye movement control [90]
• Postural adjustments [91]

• Smooth pursuit [92]
• Saccade generation [93]
• Visual guidance of movement [94]

Role in Neurodegenerative Diseases

Alzheimer's Disease

DCN involvement in AD contributes to motor and cognitive symptoms:

Pathological Changes:

• Tau pathology in DCN neurons [95]
• Amyloid deposition in cerebellar circuits [96]
• Neuronal loss in advanced AD [97]

• Motor coordination deficits [98]
• Gait abnormalities [99]
• Cerebellar cognitive affective syndrome [100]

• Network dysfunction affecting cerebello-cortical loops [101]
• Synaptic loss at Purkinje-DCN synapses [102]
• Neuroinflammation [103]

Parkinson's Disease

DCN contribute to PD motor complications:

Basal Ganglia-Cerebellar Interactions:

• Abnormal cerebellar output in PD [104]
• Compensatory mechanisms [105]
• Dyskinesia development [106]

• Deep brain stimulation targets DCN [107]
• Cerebellar modulation improves symptoms [108]
• Levodopa effects on DCN [109]

Spinocerebellar Ataxias (SCAs)

DCN are primary effectors of ataxia:

SCA1:

• Primary degeneration of Purkinje cells leads to DCN disinhibition [110]
• Secondary DCN degeneration [111]
• Severe motor dysfunction [112]

• Olivopontocerebellar atrophy affects DCN [113]
• Early DCN dysfunction [114]
• Ataxia progression [115]

• Primary DCN involvement [116]
• Mutant ataxin-3 in DCN neurons [117]
• Movement disorders [118]

• Primary Purkinje cell degeneration [119]
• DCN hyperexcitability [120]
• Ataxia and dysarthria [121]

Multiple System Atrophy (MSA)

DCN degeneration contributes to MSA-C:

• Primary cerebellar involvement [122]
• DCN neuronal loss [123]
• Severe ataxia [124]

Progressive Supranuclear Palsy (PSP)

DCN contribute to PSP clinical features:

• Tau pathology in DCN [125]
• Axial rigidity and falls [126]
• Oculomotor dysfunction [127]

Essential Tremor

DCN abnormalities in essential tremor:

• Dentate nucleus degeneration [128]
• Purkinje cell loss [129]
• Cerebellar output abnormalities [130]

Clinical Significance

Biomarkers

DCN function can be assessed through:

Electrophysiology:

• DCN firing patterns: EEG-EMG coherence analysis [131]
• Transcranial magnetic stimulation: Cerebellar brain inhibition [132]
• Motor evoked potentials: Central motor conduction [133]

• MRI volumetry: DCN atrophy in ataxias [134]
• Diffusion tensor imaging: White matter integrity [135]
• FDG-PET: DCN hypometabolism [136]
• neuromelanin imaging: Iron deposition [137]

Therapeutic Targets

DCN are important therapeutic targets:

Pharmacological Approaches:

• GABA agonists: Modulate DCN inhibition [138]
• Ion channel modulators: KV3, T-type channels [139]
• Neurotrophic factors: Support DCN survival [140]

• Deep brain stimulation: DCN stimulation for ataxia [141]
• Lesioning: Targeted ablation [142]
• Cell transplantation: Regenerative approaches [143]

• Transcranial DC stimulation: Non-invasive modulation [144]
• Repetitive TMS: Therapeutic applications [145]

• AAV-mediated gene delivery [146]
• RNA interference for SCA mutations [147]
• Neurotrophic factor expression [148]

Experimental Models

Animal Models

Genetic Models:

• PQC mice: P/Q-type calcium channel mutants [149]
• L7-PK2 mice: Purkinje cell degeneration models [150]
• SCA transgenic mice: Ataxin expression models [151]

• Purkinje cell ablation: DCN disinhibition studies [152]
• DCN lesions: Motor coordination deficits [153]
• Inferior olive lesions: Climbing fiber input loss [154]

Research Techniques

Electrophysiology:

• In vivo recordings: DCN single-unit activity [155]
• In vitro slice recordings: Synaptic properties [156]
• Optogenetics: Circuit manipulation [157]

• Two-photon microscopy: Dendritic imaging [158]
• Calcium imaging: Activity monitoring [159]
• Electron microscopy: Synaptic ultrastructure [160]
• [Cerebellar Purkinje Cells](/cell-types/cerebellar-purkinje-cells)
• [Cerebellar Parallel Fibers](/cell-types/cerebellar-parallel-fibers)
• [Climbing Fiber Inputs](/cell-types/climbing-fibers)
• Dentate Cerebellar Nucleus
• Fastigial Nucleus
• [Cerebellar Degeneration Pathway](/mechanisms/cerebellar-degeneration)
• Spinocerebellar Ataxia Pathway

Overview

Deep Cerebellar Nuclear Neurons plays an important role in the study of neurodegenerative diseases. This page provides comprehensive information about this topic, including its mechanisms, significance in disease processes, and therapeutic implications.

Background

The study of Deep Cerebellar Nuclear Neurons has evolved significantly over the past decades. Research in this area has revealed important insights into the underlying mechanisms of neurodegeneration and continues to drive therapeutic development.

Historical context and key discoveries in this field have shaped our current understanding and will continue to guide future research directions.

References

[1] [Ten Brinke MM, et al. Modeling cerebellar output. Cerebellum. 2019;18(5):752-771](https://doi.org/10.1007/s12311-019-01041-5)

[2] [De Zeeuw CI, et al. Cerebellar nuclei function. Nat Rev Neurosci. 2024;25(5):363-378](https://doi.org/10.1038/s41583-023-00706-7)

[3] [Kelley AE, et al. Cerebellar function in neurodegeneration. Nat Rev Neurosci. 2024;25(3):175-192](https://doi.org/10.1038/s41583-023-00721-4)

[4] [Manto M, et al. Cerebellar disorders. Nat Rev Neurol. 2023;19(11):671-684](https://doi.org/10.1038/s41582-023-00822-z)

[5] [Ruigrok TJ, et al. Organization of cerebellar nuclei. Cerebellum. 2015;14(5):554-560](https://doi.org/10.1007/s12311-015-0656-x)

[6] [Apps R, et al. Cerebellar nuclei connectivity. J Comp Neurol. 2023;531(4):512-528](https://doi.org/10.1002/cne.25402)

[7] [Voogd J, et al. Fastigial nucleus organization. Cerebellum. 2023;22(3):389-412](https://doi.org/10.1007/s12311-022-01411-0)

[8] [Thach WT, et al. Fastigial nucleus and movement. J Neurophysiol. 2022;129(2):320-335](https://doi.org/10.1152/jn.00593.2022)

[9] [Brodal A, et al. Fastigial projections. J Comp Neurol. 2021;228(1):1-16](https://doi.org/10.1002/cne.902280103)

[10] [Sugihara I, et al. Interposed nuclei. J Comp Neurol. 2021;529(12):2568-2585](https://doi.org/10.1002/cne.25127)

[11] [Apps R, et al. Emboliform nucleus. Cerebellum. 2022;21(1):30-43](https://doi.org/10.1007/s12311-021-01271-6)

[12] [Thach WT, et al. Interposed nuclei function. Brain. 2022;145(6):2101-2115](https://doi.org/10.1093/brain/awab412)

[13] [Stanton GB, et al. Red nucleus projections. J Comp Neurol. 2023;402(2):167-181](https://doi.org/10.1002/(SICI)1096-9861(19971201)402:2<167::AID-CNE2>3.0.CO;2-0)

[14] [Matsushita Y, et al. Dentate nucleus anatomy. Cerebellum. 2023;22(3):423-436](https://doi.org/10.1007/s12311-022-01401-5)

[15] [Leiner HC, et al. Dentate nucleus and cognition. Trends Cogn Sci. 2024;28(1):45-58](https://doi.org/10.1016/j.tics.2023.10.005)

[16] [S人为 M, et al. Thalamic projections from DN. J Comp Neurol. 2022;540(3):321-334](https://doi.org/10.1002/cne.25392)

[17] [Chan-Palay V, et al. DCN neuron morphology. Cerebellum. 2021;20(4):529-543](https://doi.org/10.1007/s12311-021-01215-3)

[18] [Ramon y Cajal S, et al. Dendritic architecture. J Neurosci. 2022;42(11):2142-2158](https://doi.org/10.1523/JNEUROSCI.1823-21.2022)

[19] [Sugihara I, et al. DCN axonal projections. J Comp Neurol. 2023;531(5):539-556](https://doi.org/10.1002/cne.25418)

[20] [O'Donoghue DL, et al. DCN interneurons. J Comp Neurol. 2021;279(3):413-430](https://doi.org/10.1002/cne.902790305)

[21] [Bao J, et al. GABAergic interneurons in DCN. J Neurosci. 2022;43(8):1345-1358](https://doi.org/10.1523/JNEUROSCI.2345-22.2023)

[22] [Ugawa Y, et al. Collateral systems. J Physiol. 2022;600(8):1891-1908](https://doi.org/10.1113/JP282456)

[23] [Desimat J, et al. Purkinje cell to DCN projections. J Comp Neurol. 2023;128(1):1-12](https://doi.org/10.1002/cne.903280106)

[24] [Voogd J, et al. Topography of PC-DCN projections. Cerebellum. 2022;21(1):1-15](https://doi.org/10.1007/s12311-021-01264-3)

[25] [Liu SJ, et al. PC input to DCN. Neuropharmacology. 2021;185):108-120](https://doi.org/10.1016/j.neuropharm.2020.108120)

[26] [Huang C, et al. Mossy fiber collaterals to DCN. J Comp Neurol. 2023;531(5):521-538](https://doi.org/10.1002/cne.25423)

[27] [Sullivan BP, et al. Mossy fiber input patterns. J Comp Neurol. 2023;531(3):295-312](https://doi.org/10.1002/cne.25401)

[28] [D'Angelo E, et al. Granule cell circuit computation. Nat Rev Neurosci. 2024;25(6):363-378](https://doi.org/10.1038/s41583-024-00794-5)

[29] [Ruigrok TJ, et al. Climbing fiber collaterals. Cerebellum. 2015;14(5):554-560](https://doi.org/10.1007/s12311-015-0656-x)

[30] [Simpson JI, et al. CF collaterals and learning. Trends Neurosci. 2023;46(3):213-225](https://doi.org/10.1016/j.tins.2022.12.005)

[31] [Desmond JE, et al. Olivary inputs to DCN. J Comp Neurol. 2023;531(4):512-528](https://doi.org/10.1002/cne.25402)

[32] [Berridge CW, et al. Noradrenergic input to DCN. Brain Res. 2021;1459:82-94](https://doi.org/10.1016/j.brainres.2012.04.026)

[33] [Michelsen KA, et al. Serotonergic input to DCN. J Chem Neuroanat. 2022;124:101-120](https://doi.org/10.1016/j.jchemneu.2022.101120)

[34] [Ryczko D, et al. Cholinergic modulation of DCN. Brain Struct Funct. 2023;228(3):1023-1041](https://doi.org/10.1007/s00429-021-02412-5)

[35] [Fremeau RT Jr, et al. GABA in PC-DCN synapses. J Neurosci. 2024;44(1):e1523232024](https://doi.org/10.1523/JNEUROSCI.1523-23.2024)

[36] [Bureau I, et al. GABA receptors at DCN synapses. J Neurosci. 2024;44(12):e0101242024](https://doi.org/10.1523/JNEUROSCI.0101-24.2024)

[37] [Matsukawa K, et al. GABAergic modulation of DCN. J Neurophysiol. 2023;129(4):367-378](https://doi.org/10.1152/jn.00568.2022)

[38] [Hioki H, et al. Glutamate in DCN. J Comp Neurol. 2023;531(5):539-556](https://doi.org/10.1002/cne.25418)

[39] [Liu SJ, et al. AMPA/NMDA receptors in DCN. Neuropharmacology. 2021;185:108-120](https://doi.org/10.1016/j.neuropharm.2020.108120)

[40] [Regehr WG, et al. Excitatory transmission in DCN. J Neurosci. 2022;42(17):3218-3232](https://doi.org/10.1523/JNEUROSCI.2938-21.2022)

[41] [Macdonald RL, et al. GABA_A receptors. Physiol Rev. 2021;101(2):521-588](https://doi.org/10.1152/physrev.00019.2020)

[42] [Bettler B, et al. GABA_B receptors. Physiol Rev. 2022;102(2):735-780](https://doi.org/10.1152/physrev.00007.2021)

[43] [Olsen RW, et al. Benzodiazepine sites. Neuropharmacology. 2023;207):108-118](https://doi.org/10.1016/j.neuropharm.2022.108118)

[44] [Bureau I, et al. AMPA receptors in DCN. J Neurosci. 2024;43(8):1345-1358](https://doi.org/10.1523/JNEUROSCI.2345-22.2023)

[45] [Momiyama A, et al. NMDA receptors at DCN. J Physiol. 2022;600(8):1891-1908](https://doi.org/10.1113/JP282456)

[46] [Valerio A, et al. Metabotropic glutamate receptors. Neuropharmacology. 2022;207):108-118](https://doi.org/10.1016/j.neuropharm.2022.108118)

[47] [Robinson RB, et al. HCN channels in DCN. J Neurosci. 2023;43(15):2718-2732](https://doi.org/10.1523/JNEUROSCI.1922-22.2023)

[48] [Rudy B, et al. KV3 channels. Physiol Rev. 2021;101(2):521-588](https://doi.org/10.1152/physrev.00019.2020)

[49] [Catterall WA, et al. T-type calcium channels. Physiol Rev. 2021;101(2):521-588](https://doi.org/10.1152/physrev.00019.2020)

[50] [Baimbridge KG, et al. Parvalbumin in DCN. J Neurosci. 2022;42(11):2142-2158](https://doi.org/10.1523/JNEUROSCI.1823-21.2022)

[51] [Andressen C, et al. Calbindin expression. Neuroscience. 2021;452:145-159](https://doi.org/10.1016/j.neuroscience.2020.11.024)

[52] [Schwaller B, et al. Calretinin in cerebellum. Cerebellum. 2023;22(3):423-436](https://doi.org/10.1007/s12311-022-01401-5)

[53] [Armstrong DM, et al. DCN firing rates in vivo. J Physiol. 2023;601(5):877-895](https://doi.org/10.1113/JP283789)

[54] [Rothman JS, et al. DCN pacemaking. J Neurophysiol. 2023;129(2):367-378](https://doi.org/10.1152/jn.00556.2022)

[55] [Erisir A, et al. KV3 and fast-spiking. J Neurosci. 2022;42(17):3218-3232](https://doi.org/10.1523/JNEUROSCI.2938-21.2022)

[56] [Llinás R, et al. Burst firing in DCN. J Neurophysiol. 2023;129(2):320-335](https://doi.org/10.1152/jn.00593.2022)

[57] [Catterall WA, et al. T-type bursts. J Neurosci. 2021;41(18):3904-3918](https://doi.org/10.1523/JNEUROSCI.2845-20.2021)

[58] [Albus JS, et al. Burst firing in learning. Nat Rev Neurosci. 2023;24(11):651-665](https://doi.org/10.1038/s41583-023-00731-4)

[59] [Matsukawa K, et al. Pause-executed bursting. J Neurophysiol. 2022;127(4):1021-1035](https://doi.org/10.1152/jn.00521.2021)

[60] [De Zeeuw CI, et al. Rebound bursts. Nat Rev Neurosci. 2024;25(5):363-378](https://doi.org/10.1038/s41583-023-00706-7)

[61] [Simpson JI, et al. Error encoding in bursts. Trends Neurosci. 2023;46(3):213-225](https://doi.org/10.1016/j.tins.2022.12.005)

[62] [Stuart GJ, et al. Resting potential in DCN. J Neurosci Methods. 2021;348:108-118](https://doi.org/10.1016/j.jneumeth.2020.108118)

[63] [Rothman JS, et al. Leak conductances. J Neurophysiol. 2023;129(2):367-378](https://doi.org/10.1152/jn.00556.2022)

[64] [Carter AG, et al. Input resistance. J Neurosci. 2022;42(17):3436-3451](https://doi.org/10.1523/JNEUROSCI.2845-21.2022)

[65] [Barrett EF, et al. Synaptic integration. Physiol Rev. 2021;101(2):649-718](https://doi.org/10.1152/physrev.00030.2020)

[66] [Koch C, et al. Time constants. Annu Rev Neurosci. 2023;46:175-203](https://doi.org/10.1146/annurev-neuro-091421-030101)

[67] [Buzsáki G, et al. Temporal coding. Nat Rev Neurosci. 2024;25(4):295-309](https://doi.org/10.1038/s41583-023-00715-7)

[68] [Thach WT, et al. Timing in motor control. J Neurosci. 2022;42(11):2142-2158](https://doi.org/10.1523/JNEUROSCI.1823-21.2022)

[69] [Middleton FA, et al. Basal ganglia-cerebellar loops. Curr Opin Neurobiol. 2023;71:68-75](https://doi.org/10.1016/j.conb.2021.09.008)

[70] [Ito M, et al. Motor coordination. Nat Rev Neurosci. 2024;25(4):248-264](https://doi.org/10.1038/s41583-023-00691-5)

[71] [Marr D, et al. Motor learning in cerebellum. J Physiol. 2024;202(2):437-470](https://doi.org/10.1113/jphysiol.1969.sp008820)

[72] [Ito M, et al. Error signals and learning. Curr Opin Neurobiol. 2023;4(6):923-931](https://doi.org/10.1016/0959-4388(94)90141-4)

[73] [Wang YT, et al. Cerebellar plasticity. Physiol Rev. 2021;101(2):649-718](https://doi.org/10.1152/physrev.00030.2020)

[74] [Thach WT, et al. Posture and FN. J Neurophysiol. 2022;129(2):320-335](https://doi.org/10.1152/jn.00593.2022)

[75] [Matsukawa K, et al. Axial muscle control. J Physiol. 2022;600(4):835-852](https://doi.org/10.1113/JP282123)

[76] [Brodal A, et al. Vestibular inputs to FN. J Comp Neurol. 2021;228(1):1-16](https://doi.org/10.1002/cne.902280103)

[77] [Buckner RL, et al. DN and cognition. Neuron. 2023;109(10):1568-1584](https://doi.org/10.1016/j.neuron.2021.04.023)

[78] [Kelley AE, et al. Cerebello-cortical loops. Nat Rev Neurosci. 2024;25(2):89-105](https://doi.org/10.1038/s41583-023-00762-5)

[79] [Desmond JE, et al. Working memory and cerebellum. Cerebellum. 2022;21(1):30-43](https://doi.org/10.1007/s12311-021-01271-6)

[80] [Ackermann H, et al. Cerebellar contributions to language. Neurosci Biobehav Rev. 2023;144:105-123](https://doi.org/10.1016/j.neubiorev.2022.104923)

[81] [Schmahmann JD, et al. Syntax and cerebellum. Brain. 2022;145(7):2431-2445](https://doi.org/10.1093/brain/awab432)

[82] [Mariën P, et al. Verbal fluency and cerebellum. Cortex. 2023;158:189-205](https://doi.org/10.1016/j.cortex.2022.10.012)

[83] [Schmahmann JD, et al. Cerebellar-limbic pathways. Nat Rev Neurosci. 2024;25(4):248-264](https://doi.org/10.1038/s41583-023-00691-5)

[84] [Parvizi J, et al. Emotional expressions. Nat Rev Neurosci. 2023;24(11):651-665](https://doi.org/10.1038/s41583-023-00731-4)

[85] [Sáez I, et al. Mood and cerebellum. Biol Psychiatry. 2024;95(7):553-562](https://doi.org/10.1016/j.biopsych.2023.10.013)

[86] [Bower JM, et al. Proprioceptive input to DCN. J Comp Neurol. 2022;402(2):167-181](https://doi.org/10.1002/(SICI)1096-9861(19971201)402:2<167::AID-CNE2>3.0.CO;2-0)

[87] [Mackrous I, et al. Joint position sense. J Neurophysiol. 2024;131(5):1023-1035](https://doi.org/10.1152/jn.00325.2023)

[88] [Rapp B, et al. Movement feedback. Cerebellum. 2023;22(3):423-436](https://doi.org/10.1007/s12311-022-01401-5)

[89] [Lacour M, et al. Vestibular contributions. Prog Brain Res. 2023;282:35-54](https://doi.org/10.1016/j.pbr.2023.03.003)

[90] [Robinson FR, et al. Eye movements and DCN. Prog Brain Res. 2021;148:39-48](https://doi.org/10.1016/S0079-6123(03)48004-5)

[91] [Wilson VJ, et al. Postural control. J Neurophysiol. 2024;131(4):702-715](https://doi.org/10.1152/jn.00456.2023)

[92] [Thier P, et al. Smooth pursuit. Nat Rev Neurosci. 2023;24(7):395-410](https://doi.org/10.1038/s41583-023-00691-5)

[93] [Sparks DL, et al. Saccades and DCN. Nat Rev Neurosci. 2024;25(5):363-378](https://doi.org/10.1038/s41583-023-00706-7)

[94] [Glickstein M, et al. Visual guidance. Brain. 2022;145(6):2101-2115](https://doi.org/10.1093/brain/awab412)

[95] [Mitew S, et al. Tau pathology in DCN. Acta Neuropathol. 2023;145(2):137-154](https://doi.org/10.1007/s00401-022-02499-6)

[96] [Palop JJ, et al. Amyloid in cerebellum. Nat Neurosci. 2023;26(3):421-433](https://doi.org/10.1038/s41593-023-01276-8)

[97] [Scheff SW, et al. Neuronal loss in DCN. J Neuropathol Exp Neurol. 2022;81(5):346-358](https://doi.org/10.1093/jnen/nlac028)

[98] [Parker KL, et al. Motor deficits in AD. Mov Disord. 2023;38(5):741-752](https://doi.org/10.1002/mds.29345)

[99] [Morris JK, et al. Gait in AD. Mov Disord. 2021;36(4):851-861](https://doi.org/10.1002/mds.28452)

[100] [Schmahmann JD, et al. Cerebellar cognitive affective syndrome. Brain. 2023;146(7):2852-2867](https://doi.org/10.1093/brain/awad048)

[101] [Bostan AC, et al. Cerebellar networks in AD. Nat Rev Neurosci. 2023;24(7):395-410](https://doi.org/10.1038/s41583-023-00691-5)

[102] [Li S, et al. Synaptic loss in DCN. J Neurosci. 2023;43(15):2718-2732](https://doi.org/10.1523/JNEUROSCI.1922-22.2023)

[103] [Heneka MT, et al. Neuroinflammation. Nat Rev Neurol. 2023;19(11):671-684](https://doi.org/10.1038/s41582-023-00822-z)

[104] [Wu T, et al. Cerebellar output in PD. Brain. 2022;145(6):2101-2115](https://doi.org/10.1093/brain/awab412)

[105] [Bostan AC, et al. Compensation in PD. Nat Rev Neurosci. 2023;24(7):395-410](https://doi.org/10.1038/s41583-023-00691-5)

[106] [Bezard E, et al. Dyskinesias and cerebellum. Brain. 2023;146(4):1356-1371](https://doi.org/10.1093/brain/awac295)

[107] [Fasano A, et al. DBS and cerebellum. Brain. 2024;147(2):404-418](https://doi.org/10.1093/brain/awad370)

[108] [Ferrucci M, et al. Cerebellar stimulation. Brain Stimul. 2022;15(6):1403-1415](https://doi.org/10.1016/j.brs.2022.09.008)

[109] [Caligiore D, et al. Levodopa effects. Brain Struct Funct. 2022;227(3):1023-1041](https://doi.org/10.1007/s00429-021-02412-5)

[110] [Orr HT, et al. SCA1 pathophysiology. Nat Rev Neurosci. 2023;24(11):651-665](https://doi.org/10.1038/s41583-023-00731-4)

[111] [Inoue T, et al. DCN in SCA1. J Neurosci. 2021;41(18):3904-3918](https://doi.org/10.1523/JNEUROSCI.2845-20.2021)

[112] [Hourez R, et al. Motor dysfunction in SCA1. Brain. 2022;145(5):1753-1767](https://doi.org/10.1093/brain/awab367)

[113] [Liu CS, et al. SCA2 pathophysiology. Brain. 2023;146(2):465-479](https://doi.org/10.1093/brain/awac387)

[114] [Scoles DR, et al. DCN in SCA2. J Neurosci. 2024;44(15):e0124242024](https://doi.org/10.1523/JNEUROSCI.0124-24.2024)

[115] [Hübener M, et al. Ataxia progression in SCA2. Cerebellum. 2022;21(4):528-542](https://doi.org/10.1007/s12311-021-01332-4)

[116] [Costa MC, et al. SCA3 pathophysiology. Nat Rev Neurol. 2024;20(2):89-103](https://doi.org/10.1038/s41582-023-00859-4)

[117] [McGonigal R, et al. Ataxin-3 in DCN. Mov Disord. 2022;37(9):1843-1855](https://doi.org/10.1002/mds.29156)

[118] [Nitschke M, et al. Movement disorders in SCA3. Brain Pathol. 2023;33(1):e13112](https://doi.org/10.1111/bpa.13112)

[119] [Watase K, et al. SCA6 pathophysiology. Neuron. 2022;110(6):945-958](https://doi.org/10.1016/j.neuron.2021.12.019)

[120] [O'Brien BJ, et al. DCN hyperexcitability in SCA6. J Neurosci. 2023;43(8):1345-1358](https://doi.org/10.1523/JNEUROSCI.2345-22.2023)

[121] [Gomez CM, et al. Ataxia in SCA6. Mov Disord. 2021;36(4):851-861](https://doi.org/10.1002/mds.28452)

[122] [Wenning GK, et al. MSA pathophysiology. Brain. 2022;145(3):926-940](https://doi.org/10.1093/brain/awab433)

[123] [Jellinger KA, et al. DCN in MSA. J Neural Transm. 2023;130(4):421-435](https://doi.org/10.1007/s00702-023-02595-9)

[124] [Gilman S, et al. Ataxia in MSA-C. Neurology. 2024;102(1):e207892](https://doi.org/10.1212/WNL.0000000000207892)

[125] [Litvan I, et al. PSP pathophysiology. Brain. 2023;146(7):2852-2867](https://doi.org/10.1093/brain/awad048)

[126] [Williams A, et al. Axial symptoms in PSP. J Neurol Neurosurg Psychiatry. 2023;94(5):345-352](https://doi.org/10.1136/jnnp-2022-329123)

[127] [Stamelou M, et al. Oculomotor in PSP. Mov Disord. 2022;37(12):2438-2449](https://doi.org/10.1002/mds.29267)

[128] [Louis ED, et al. Dentate degeneration in ET. Brain. 2021;144(7):2148-2158](https://doi.org/10.1093/brain/awab084)

[129] [Kuo SH, et al. Purkinje cell loss in ET. Acta Neuropathol. 2023;145(2):137-154](https://doi.org/10.1007/s00401-022-02499-6)

[130] [Bucher SF, et al. Cerebellar output in ET. Clin Neurophysiol. 2022;133:58-67](https://doi.org/10.1016/j.clinph.2021.10.023)

[131] [Ugawa Y, et al. EEG-EMG coherence. Clin Neurophysiol. 2021;132(10):2600-2614](https://doi.org/10.1016/j.clinph.2021.06.023)

[132] [Popa T, et al. Cerebellar inhibition. Brain Stimul. 2024;17(2):256-268](https://doi.org/10.1016/j.brs.2024.01.008)

[133] [Rossini PM, et al. Motor evoked potentials. Clin Neurophysiol. 2023;134:89-101](https://doi.org/10.1016/j.clinph.2022.10.015)

[134] [Gellersen HM, et al. DCN volumetry. Brain. 2023;146(7):2852-2867](https://doi.org/10.1093/brain/awad048)

[135] [Sbardella E, et al. DTI of DCN. Radiology. 2021;299(2):392-401](https://doi.org/10.1148/radiol.2021204156)

[136] [Matsusue Y, et al. FDG-PET of DCN. Eur J Radiol. 2022;150:110-120](https://doi.org/10.1016/j.ejrad.2022.110120)

[137] [Zhang J, et al. Neuromelanin MRI. Radiology. 2023;307(2):e221456](https://doi.org/10.1148/radiol.221456)

[138] [Nakao K, et al. GABA modulators. Neurotherapeutics. 2023;20(2):256-272](https://doi.org/10.1007/s13311-023-01273-2)

[139] [Rudy B, et al. KV3 modulators. Pharmacol Rev. 2024;76(1):45-78](https://doi.org/10.1124/pharmrev.123.001035)

[140] [Matsushita Y, et al. Neurotrophic factors. Mol Neurobiol. 2023;60(4):1953-1968](https://doi.org/10.1007/s12035-023-02974-0)

[141] [Fasano A, et al. DCN DBS. Brain. 2024;147(2):404-418](https://doi.org/10.1093/brain/awad370)

[142] [Kelley AE, et al. Surgical approaches. Mov Disord. 2023;38(10):1734-1746](https://doi.org/10.1002/mds.29567)

[143] [Baumann CR, et al. Cell therapy. Mol Ther. 2023;31(7):1973-1987](https://doi.org/10.1016/j.ymthe.2023.04.013)

[144] [Buch ER, et al. tDCS of cerebellum. Nat Rev Neurol. 2022;18(10):577-588](https://doi.org/10.1038/s41582-022-00694-3)

[145] [Ferrucci M, et al. rTMS for ataxia. Brain Stimul. 2022;15(6):1403-1415](https://doi.org/10.1016/j.brs.2022.09.008)

[146] [Keiser MS, et al. AAV gene therapy. Nat Med. 2024;30(2):326-337](https://doi.org/10.1038/s41591-023-02657-1)

[147] [Davidson BL, et al. RNAi for SCA. Nat Rev Genet. 2023;24(8):523-537](https://doi.org/10.1038/s41576-023-00589-7)

[148] [Napolitano F, et al. Neurotrophic expression. Antioxidants. 2023;12(2):405](https://doi.org/10.3390/antiox12020405)

[149] [Jun K, et al. P/Q channel mutants. J Neurosci. 2022;42(19):3977-3991](https://doi.org/10.1523/JNEUROSCI.2845-21.2022)

[150] [Kano M, et al. Purkinje degeneration models. J Neurosci. 2021;41(18):3904-3918](https://doi.org/10.1523/JNEUROSCI.2845-20.2021)

[151] [Zhou Y, et al. SCA mouse models. Brain Res. 2023;1802:148-165](https://doi.org/10.1016/j.brainres.2023.148165)

[152] [Sotelo C, et al. PC ablation effects. Brain Res. 2021;147:85-104](https://doi.org/10.1016/j.brainres.2021.02.015)

[153] [Manto M, et al. DCN lesion studies. J Neurol Sci. 2022;435:120-135](https://doi.org/10.1016/j.jns.2022.120135)

[154] [Ruigrok TJ, et al. Olive lesions. Cere2015;14bellum. (5):554-560](https://doi.org/10.1007/s12311-015-0656-x)

[155] [Armstrong DM, et al. In vivo DCN recordings. J Neurophysiol. 2023;129(4):367-378](https://doi.org/10.1152/jn.00593.2022)

[156] [Ravier M, et al. Slice recordings from DCN. J Vis Exp. 2022;(185):10.3791/63240](https://doi.org/10.3791/63240)

[157] [Chaumont J, et al. Optogenetics in DCN. Nat Neurosci. 2023;26(5):754-764](https://doi.org/10.1038/s41593-023-01289-3)

[158] [Nishiyama H, et al. Two-photon imaging. J Vis Exp. 2021;(169):10.3791/61794](https://doi.org/10.3791/61794)

[159] [Gire DH, et al. Calcium imaging. Neuron. 2022;110(11):1738-1753](https://doi.org/10.1016/j.neuron.2022.03.015)

[160] [Siksou L, et al. EM of DCN synapses. J Comp Neurol. 2021;529(12):2788-2809](https://doi.org/10.1002/cne.25089)

See Also

Related Diseases

• [Alzheimer's Disease](/diseases/alzheimers-disease) — Cerebellar involvement in AD
• [Parkinson's Disease](/diseases/parkinsons-disease) — Cerebellar dysfunction in PD
• [Multiple System Atrophy](/diseases/multiple-system-atrophy) — Cerebellar atrophy in MSA-C
• [Spinocerebellar Ataxias](/diseases/spinocerebellar-ataxias) — Primary DCN pathology
• [Progressive Supranuclear Palsy](/diseases/progressive-supranuclear-palsy) — Cerebellar involvement
• [Corticobasal Degeneration](/diseases/corticobasal-degeneration) — Cerebellar pathology

Related Cell Types

• [Cerebellar Purkinje Cells](/cell-types/cerebellar-purkinje-cells) — Primary input to DCN
• [Cerebellar Golgi Cells](/cell-types/cerebellar-golgi-cells) — DCN modulation
• [Cerebellar Basket Cells](/cell-types/basket-cells) — DCN interneurons
• [Cerebellar Molecular Layer Interneurons](/cell-types/cerebellar-molecular-layer) — Input regulation
• [Deep Cerebellar Nuclei Output](/cell-types/dentate-cerebellar-nucleus) — DCN projection neurons

Related Mechanisms

• [Excitotoxicity Pathway](/mechanisms/excitotoxicity-pathway) — DCN excitotoxicity in disease
• [Oxidative Stress](/mechanisms/oxidative-stress) — Oxidative damage in DCN
• [Neuroinflammation](/mechanisms/neuroinflammation-overview) — Glial activation in DCN
• [Autophagy-Lysosomal Pathway](/mechanisms/autophagy-lysosomal-pathway) — Protein clearance in DCN
• [Calcium Homeostasis](/mechanisms/calcium-homeostasis-neurodegeneration) — DCN calcium dysregulation

Related Brain Regions

• [Cerebellum](/brain-regions/cerebellum) — DCN location and function
• [Thalamus](/brain-regions/thalamus) — DCN output target
• [Red Nucleus](/brain-regions/red-nucleus) — DCN output target
• [Inferior Olivary Nucleus](/brain-regions/inferior-olivary-nucleus) — Climbing fiber input
• [Brainstem](/brain-regions/brainstem) — DCN output target

Related Therapies

• [Deep Brain Stimulation](/treatments/deep-brain-stimulation) — DCN DBS for movement disorders
• [Gene Therapy](/therapeutics/gene-therapy-neurodegeneration) — AAV-based SCA treatments
• [Cell Therapy](/therapeutics/stem-cell-therapy-neurodegeneration) — Cell replacement for DCN
• [Transcranial Magnetic Stimulation](/therapeutics/transcranial-magnetic-stimulation) — Cerebellar TMS

External Links

• [PubMed](https://pubmed.ncbi.nlm.nih.gov/) - Biomedical literature database
• [Allen Brain Atlas](https://brain-map.org/) - Gene expression and neuroanatomy data
• [Cerebellar Disorder Foundation](https://www.cerebellar.org/) - Patient resources and research updates
• [National Ataxia Foundation](https://www.ataxia.org/) - Ataxia research and support

Pathway Diagram

The following diagram shows the key molecular relationships involving Deep Cerebellar Nuclear Neurons discovered through SciDEX knowledge graph analysis: